BGF Investment Management’s €6 Million Investment in Vasorum Ltd

Dillon Eustace acted on behalf of limited partnerships BGF Ireland 1A and BGF Investments, both managed by BGF Investment Management.

BGF announced its €6 million investment in Vasorum Ltd.

The investment represents major growth for Vasorum Ltd and a strategic addition to BGF’s portfolio.

Vasorum Ltd, founded in 2007, is an Irish medical device research and development company supported by Enterprise Ireland, which develops medical devices for the interventional cardiology and radiology markets. The company operating from Dublin has more than 30,000 patient implants to date in both the EU and USA.

BGF, investor in growth companies, was established in 2011 and has so far invested in over 300 companies, this investment is part of the firm’s €250 million fund dedicated to growth funding in Ireland. 

The Dillon Eustace legal team on this transaction was led by Lorcan Tiernan (Picture), Partner and Head of Corporate M&A, and supported by M&A Solicitor Owen Brayden, with UK firm Potter Clarkson providing intellectual property advice. 

Involved fees earner: Owen Brayden – Dillon Eustace Solicitors; Lorcan Tiernan – Dillon Eustace Solicitors;

Law Firms: Dillon Eustace Solicitors;

Clients: BGF Investment Management; BGF Ireland 1A;

Federica Tiefenthaler

Author: Federica Tiefenthaler